]>
IRCT2013082714333N3 IRCT 2013-09-23 Kermanshah University of Medical Sciences Evaluation of Fluconazole treatment effects on acute biliary pancreatitis copmarsion of treatment effects with and without the use of Fluconazole on acute biliary pancreatitis 2013-05-22 anticipated 76 Complete https://irct.ir/trial/13939 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A biliary acute pancreatitis. Intervention 1: routine treatment (included Restriction of oral intake, correction of water and electrolyte, pain management intravenous fluids and, monitoring of central venous pressure, urine output controls the prescription of prophylactic antibiotics) to control group. Intervention 2: Fluconazole is added to the treatment regimen for five days in the intervention group.
public
scientific Dr. Seyed Mohamad Ali Hesami
Dep.surgery,Emam Reza Hospital,Razi Boulvard,Sorkhleje
Kermanshah Iran (Islamic Republic of) +98 931 427 6308 mahessami@hotmail.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria:patients consists of those who have been diagnosed with acute biliary pancreatitis based on clinical; laboratory and ultrasound results.criteria excluded: Pregnant women; patients with a history of previous hypersensitivity to fluconazole to mention; person that any allergies or suffer from the study. no limit no limit Both k85.1 biliary acute pancreatitis Treatment - Drugs Treatment - Drugs routine treatment (included Restriction of oral intake, correction of water and electrolyte, pain management intravenous fluids and, monitoring of central venous pressure, urine output controls the prescription of prophylactic antibiotics) to control group Fluconazole is added to the treatment regimen for five days in the intervention group Severity of disease. Timepoint: at starting point and six months later. Method of measurement: Based on Ratson criteria and CT. Scan. Necessity to operation. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Duration of staying in hospita. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Duration of staying in hospital. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Costs of disease. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Treatments. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Complications. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Mortality rate. Timepoint: at starting point and 6 months later. Method of measurement: based on patient records. Kermanshah University of Medical Sciences Approved 2013-05-18 Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences Building No.2, Shahid Beheshti, Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences Kermanshah Iran (Islamic Republic of)